Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.490
-0.020 (-0.80%)
At close: Feb 5, 2026
Integral Diagnostics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 4.67 | -60.7 | 25.04 | 14.6 | 31.27 |
Depreciation & Amortization | 50.43 | 41.53 | 43.49 | 36.7 | 34.91 |
Other Amortization | 7.29 | 5.77 | 0.39 | 0.41 | 0.43 |
Loss (Gain) From Sale of Assets | 0.06 | -0.02 | 0.02 | -0.18 | 0.42 |
Asset Writedown & Restructuring Costs | 0.54 | 74.64 | - | - | - |
Loss (Gain) on Equity Investments | - | 0.06 | 0.33 | 0.16 | -0.02 |
Stock-Based Compensation | 1.22 | 1.37 | 2.21 | -0.64 | 2.08 |
Provision & Write-off of Bad Debts | 1.17 | 0.64 | 0.36 | -0.21 | 0.09 |
Other Operating Activities | -3.63 | -1.11 | -16.5 | -1.59 | -1.32 |
Change in Accounts Receivable | -0.03 | -3.25 | -0.35 | -3.44 | -2.92 |
Change in Accounts Payable | 3.77 | 1.69 | 3.16 | 0.43 | 0.74 |
Change in Unearned Revenue | -1.08 | -0.04 | -0.08 | - | - |
Change in Income Taxes | 1.49 | -0.25 | 5.36 | -9.2 | -0.8 |
Change in Other Net Operating Assets | 6.87 | 0.54 | 5.63 | 0.7 | 6.57 |
Operating Cash Flow | 73.77 | 66.16 | 67.28 | 37.1 | 69.57 |
Operating Cash Flow Growth | 11.51% | -1.66% | 81.34% | -46.67% | 28.24% |
Capital Expenditures | -59.76 | -23.88 | -44 | -27.77 | -20.26 |
Sale of Property, Plant & Equipment | 0.31 | - | - | - | - |
Cash Acquisitions | 14.93 | -4.03 | -84.96 | -27.92 | -36.39 |
Sale (Purchase) of Intangibles | - | - | - | - | -0.01 |
Other Investing Activities | -20.48 | - | - | - | - |
Investing Cash Flow | -64.99 | -27.9 | -128.96 | -55.69 | -56.66 |
Long-Term Debt Issued | 343.38 | - | 43.05 | 114.15 | 35.18 |
Long-Term Debt Repaid | -326.65 | -17.35 | -60.19 | -101.11 | -26.78 |
Net Debt Issued (Repaid) | 16.73 | -17.35 | -17.14 | 13.04 | 8.4 |
Issuance of Common Stock | - | - | 2.2 | 91.83 | 1.79 |
Common Dividends Paid | -15.46 | -12.1 | -12.64 | -20.86 | -17.89 |
Other Financing Activities | -0.56 | - | - | -2.88 | -0.14 |
Financing Cash Flow | 0.71 | -29.45 | -27.58 | 81.13 | -7.83 |
Foreign Exchange Rate Adjustments | 0.18 | -0.22 | 0.05 | -1.55 | -0.84 |
Miscellaneous Cash Flow Adjustments | - | - | -0.13 | - | - |
Net Cash Flow | 9.67 | 8.58 | -89.34 | 60.99 | 4.24 |
Free Cash Flow | 14.01 | 42.28 | 23.28 | 9.33 | 49.31 |
Free Cash Flow Growth | -66.86% | 81.61% | 149.53% | -81.08% | 73.80% |
Free Cash Flow Margin | 2.23% | 9.00% | 5.28% | 2.58% | 14.06% |
Free Cash Flow Per Share | 0.04 | 0.18 | 0.10 | 0.04 | 0.25 |
Cash Interest Paid | 30.73 | 22.12 | 17.81 | 10.33 | 10.32 |
Cash Income Tax Paid | 4.01 | -1.71 | 1.99 | 17.45 | 16.73 |
Levered Free Cash Flow | 57.44 | 37.44 | 20.14 | 16.84 | 48.41 |
Unlevered Free Cash Flow | 74.23 | 50.95 | 31.18 | 22.98 | 53.49 |
Change in Working Capital | 12.03 | 3.98 | 11.95 | -12.15 | 1.71 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.